Cargando…

A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies

Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies (MOG-Abs) are commonly associated with clinical presentations as acute disseminated encephalomyelitis (ADEM) in both adults and children and anti-aquaporin 4 antibody-seronegative neuromyelitis optica spectrum disorder (NMOSD) and related syn...

Descripción completa

Detalles Bibliográficos
Autores principales: Hochmeister, Sonja, Gattringer, Thomas, Asslaber, Martin, Stangl, Verena, Haindl, Michaela Tanja, Enzinger, Christian, Höftberger, Romana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034704/
https://www.ncbi.nlm.nih.gov/pubmed/32117004
http://dx.doi.org/10.3389/fneur.2020.00031
_version_ 1783499926375759872
author Hochmeister, Sonja
Gattringer, Thomas
Asslaber, Martin
Stangl, Verena
Haindl, Michaela Tanja
Enzinger, Christian
Höftberger, Romana
author_facet Hochmeister, Sonja
Gattringer, Thomas
Asslaber, Martin
Stangl, Verena
Haindl, Michaela Tanja
Enzinger, Christian
Höftberger, Romana
author_sort Hochmeister, Sonja
collection PubMed
description Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies (MOG-Abs) are commonly associated with clinical presentations as acute disseminated encephalomyelitis (ADEM) in both adults and children and anti-aquaporin 4 antibody-seronegative neuromyelitis optica spectrum disorder (NMOSD) and related syndromes such as optic neuritis, myelitis, and brainstem encephalitis. Most often, the presence of MOG-Abs is associated with a more benign clinical course and a good response to steroids. Here, we present a case report of a previously healthy 52-year-old female patient with fulminant demyelinating encephalitis, leading to death within a week after the first presenting symptoms from a massive brain edema irresponsive to high-dose intravenous steroids as well as osmotic therapy. The final diagnosis was only made postmortem after serum anti-MOG-Abs results were available. Histopathological analysis of the brain revealed extensive, predominantly cortical demyelinating lesions in the frontal, temporal, and parietal lobes with intracortical, leukocortical, and subpial plaques, associated with pronounced perivenous deposition of activated complement complex as well as features of acute MS characterized by destructive lesions.
format Online
Article
Text
id pubmed-7034704
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70347042020-02-28 A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies Hochmeister, Sonja Gattringer, Thomas Asslaber, Martin Stangl, Verena Haindl, Michaela Tanja Enzinger, Christian Höftberger, Romana Front Neurol Neurology Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies (MOG-Abs) are commonly associated with clinical presentations as acute disseminated encephalomyelitis (ADEM) in both adults and children and anti-aquaporin 4 antibody-seronegative neuromyelitis optica spectrum disorder (NMOSD) and related syndromes such as optic neuritis, myelitis, and brainstem encephalitis. Most often, the presence of MOG-Abs is associated with a more benign clinical course and a good response to steroids. Here, we present a case report of a previously healthy 52-year-old female patient with fulminant demyelinating encephalitis, leading to death within a week after the first presenting symptoms from a massive brain edema irresponsive to high-dose intravenous steroids as well as osmotic therapy. The final diagnosis was only made postmortem after serum anti-MOG-Abs results were available. Histopathological analysis of the brain revealed extensive, predominantly cortical demyelinating lesions in the frontal, temporal, and parietal lobes with intracortical, leukocortical, and subpial plaques, associated with pronounced perivenous deposition of activated complement complex as well as features of acute MS characterized by destructive lesions. Frontiers Media S.A. 2020-02-14 /pmc/articles/PMC7034704/ /pubmed/32117004 http://dx.doi.org/10.3389/fneur.2020.00031 Text en Copyright © 2020 Hochmeister, Gattringer, Asslaber, Stangl, Haindl, Enzinger and Höftberger. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Hochmeister, Sonja
Gattringer, Thomas
Asslaber, Martin
Stangl, Verena
Haindl, Michaela Tanja
Enzinger, Christian
Höftberger, Romana
A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies
title A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies
title_full A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies
title_fullStr A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies
title_full_unstemmed A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies
title_short A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies
title_sort fulminant case of demyelinating encephalitis with extensive cortical involvement associated with anti-mog antibodies
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034704/
https://www.ncbi.nlm.nih.gov/pubmed/32117004
http://dx.doi.org/10.3389/fneur.2020.00031
work_keys_str_mv AT hochmeistersonja afulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies
AT gattringerthomas afulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies
AT asslabermartin afulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies
AT stanglverena afulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies
AT haindlmichaelatanja afulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies
AT enzingerchristian afulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies
AT hoftbergerromana afulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies
AT hochmeistersonja fulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies
AT gattringerthomas fulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies
AT asslabermartin fulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies
AT stanglverena fulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies
AT haindlmichaelatanja fulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies
AT enzingerchristian fulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies
AT hoftbergerromana fulminantcaseofdemyelinatingencephalitiswithextensivecorticalinvolvementassociatedwithantimogantibodies